The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Ropes & Gray LLP

800 BOYLSTON STREET, BOSTON, MA 02199, USA
Tel:
Work +1 617 951 7000
Web:
www.ropesgray.com
Boston, Central Hong Kong, Chicago, East Palo Alto, London EC4A, London EC4M and 6 more

Paul Kinsella

Ropes & Gray LLP

Position

Paul represents companies in business combinations, securities offerings, and corporate governance matters. Examples of 2015 M&A transactions include advising: •Cubist in its sale to Merck for $9.5 billion. • Pfizer in its pending acquisition of Hospira for approximately $17 billion. •Wright Medical in its pending merger of equals with Tornier. Examples of 2015 securities offerings include advising: •Wright Medical in a $632.5 million convertible note offering. •Novavax in a $201.25 million equity offering. • Akebia in a $65 million equity offering. https://www.ropesgray.com/biographies/k/paul-m-kinsella.aspx?AK=kinsel#sthash.IIKU5vWd.dpuf


United States: Finance

Capital markets: equity offerings

Within: Capital markets: equity offerings

The ‘outstanding’ capital markets team at Ropes & Gray LLP is regarded by many as ‘a go-to practice for private equity funds’ - its client base also encompasses corporate issuers and investment banks. Jointly led from Boston by Patrick O’Brien and Paul Kinsella, the large national group also includes key practitioners in San Francisco and New York. In a major coup, San Francisco’s Thomas Holden advised Canada Goose Holdings, as the issuer, and Bain Capital, as a selling shareholder, on both Canada Goose’s C$340m IPO and its $259m follow-on offering. In another cross-border highlight, O’Brien, together with the firm’s Shanghai and Hong Kong offices, advised China-based biotechnology company Zai Lab on its $172.5m IPO. Boston partners David Fine and Craig Marcus advised Planet Fitness on three separate follow-on offerings worth $306m, $326m and $348m respectively.

[back to top]

United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

Ropes & Gray LLP’s team often advises clients on high-profile corporate and litigation matters. Co-chair Gregory Levine, along with Zach Blume and Paul Kinsella, led advice to Aegerion Pharmaceuticals on various contentious and non-contentious issues, including the negotiation of a consent decree with the FDA and DOJ. Michael Beauvais assisted Bain Capital with a $55m financing and investment round for German biopharmaceutical company InflaRx. David McIntosh acted for Akebia Therapeutics on various corporate transactions, including a number of major licensing agreements. The team, which includes the well-regarded Steven Wilcox, Mark Bellomy and Marc Rubenstein, was bolstered by the arrivals of Paul Scrivano in San Francisco from O'Melveny & Myers LLP and David Blittner in New York from Weil, Gotshal & Manges LLP. All partners are based in Washington DC and Boston unless otherwise stated.

[back to top]

United States: M&A/corporate and commercial

M&A: large deals ($1bn+)

Within: M&A: large deals ($1bn+)

Ropes & Gray LLP is gaining further ground on its rivals, particularly through the build-out of its New York office and its growing presence on the West Coast. In 2017, the firm hired Bay Area giant Paul Scrivano as global head of the M&A practice. He brings considerable experience in technology sector deals, most notably in the semiconductors space. Nationwide the firm remains a leader in life sciences and healthcare, and in the asset management sector. It has also made considerable headway in representing financial advisers to M&A transactions, particularly following the recruitment of John Sorkin in 2015. He and his team have cemented stronger relationships to key investment banks, enabling the firm to increase its market share of financial adviser roles, but also gain recommendations and referrals from influential bankers. It continues to be recognized as a leader in private equity, which frequently leads to prime strategic M&A engagements, and is able to provide support in Food and Drug Administration (FDA) matters, tax, data privacy, intellectual property and executive compensation. It advised cornerstone client Bain Capital on a Bain-led consortium’s $18bn acquisition of Toshiba Memory from Toshiba Corporation, reported to be the largest Japanese deal since 2011 and the largest private equity and leveraged finance deal ever in Asia. A team led by Scrivano advised Mentor Graphics on its $4.5bn acquisition by Siemens Industry. In another major deal, the firm advised Multi Packaging Solutions on its $2.28bn acquisition by WestRock, one of the world’s leading paper and packaging providers. Other clients include Bright Horizons, Covidien, Dunkin’ Brands Group, Habit Restaurants, Marquee Brands, Pfizer, Planet Fitness and Reebok International. Other key partners include New York and Boston based Jane Goldstein, who is co-head of the M&A group, Christopher Comeau, who is recommended for large-cap life sciences deals, and chair-elect Julie Jones, who covers both private equity buyouts and strategic M&A. Paul Kinsella is also recommended for life sciences, pharmaceuticals and biotech transactions. New York-based Othon Prounis and Carl Marcellino are also noted for their mix of strategic M&A and private equity. Named partners are based in Boston unless stated otherwise.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to